e.g. Tata motors, Reliance MF, 500570

Jagsonpal Pharmaceuticals Ltd. - Research Center

507789 JAGSNPHARM Group (B) BSE data
 
Back to Company Page
Results:

Quarterly results in brief

(Rs crore)
Jun' 26 Mar' 26 Dec' 25 Sep' 25 Jun' 25
Sales 82.23 64.20 72.95 74.47 75.61
Operating profit 17.24 11.16 16.27 16.43 14.21
Interest 0.25 0.25 0.26 0.27 0.25
Gross profit 19.82 14.08 18.99 19.20 16.78
EPS (Rs) 2.00 1.31 1.64 1.89 1.62

Quarterly  results in details

Jun' 26 Mar' 26 Dec' 25 Sep' 25 Jun' 25
Other income 2.83 3.17 2.98 3.03 2.83
Stock adjustment -2.29 0.89 -0.31 -0.41 -1.09
Raw material 4.87 2.99 3.95 3.84 5.33
Power and fuel - - - - -
Employee expenses 22.78 15.55 17.30 16.55 17.94
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 39.64 33.62 35.74 38.06 39.22
Provisions made - - - - -
Depreciation 2.14 2.32 2.39 2.39 2.35
Taxation 4.49 2.99 3.57 4.24 3.64
Net profit / loss 13.19 8.76 10.95 12.57 10.80
Extra ordinary item - - -2.08 - -
Prior year adjustments - - - - -
Equity capital 13.17 13.39 13.36 13.33 13.31
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 20.97 17.38 22.30 22.07 18.80
GPM (%) 23.30 20.89 25.01 24.77 21.40
NPM (%) 15.50 13.01 14.42 16.23 13.76
Close
Add Jagsonpal Pharmaceuticals Ltd. to your Portfolio
 
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Jagsonpal Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback